HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chitinase-3-like Protein 1 (YKL-40) Expression in Squamous Cell Skin Cancer.

AbstractBACKGROUND/AIM:
YKL-40 plays a role in proliferation and differentiation of malignant cells. The aim of this study was to examine whether YKL-40 is expressed in cutaneous squamous cell carcinoma (SCC).
MATERIALS AND METHODS:
The study was based on histologically-confirmed biopsies of cutaneous SCCs obtained from 38 patients. The tissue expression of YKL-40 was assessed using an immunohisto-chemical method. The percentage of cells showing a positive reaction as well as the intensity of the IHC reaction was assessed using the immunoreactive score developed by Remmele and Stegner.
RESULTS:
All samples of cutaneous SCCs showed cytoplasmic expression of YKL-40. The intensity of YKL-40 expression varied between 1 and 8 points, according to the applied scale. In the majority of cancers about 10-80% of tumor cells were positive for YKL-40. The intensity of the reaction was low (20 samples, 52.6%) or medium (18 samples, 47.4%).
CONCLUSION:
YKL-40 is expressed in cutaneous SCC. Further research is needed to establish the value of YKL-40 for diagnosis and monitoring of SCC.
AuthorsJoanna Salomon, Aleksandra Piotrowska, Łukasz Matusiak, Piotr Dzięgiel, Jacek C Szepietowski
JournalAnticancer research (Anticancer Res) Vol. 38 Issue 8 Pg. 4753-4758 (Aug 2018) ISSN: 1791-7530 [Electronic] Greece
PMID30061245 (Publication Type: Journal Article)
CopyrightCopyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Chemical References
  • Biomarkers, Tumor
  • CHI3L1 protein, human
  • Chitinase-3-Like Protein 1
Topics
  • Biomarkers, Tumor (biosynthesis, blood)
  • Carcinoma, Squamous Cell (pathology)
  • Chitinase-3-Like Protein 1 (biosynthesis, blood)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry (methods)
  • Retrospective Studies
  • Skin Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: